Human Intestinal Organoid Screening

APPLICATION NOTE

An automated workflow for anti cancer drug toxicity evaluation using patient derived healthy intestinal organoids with suspension culture and AI enabled image analysis

Application note on Human Intestinal Organoid Screening

Gain Deeper Toxicity Insights with Automated Human Intestinal Organoid Screening

Discover how an automated workflow combining the CellXpress.ai® Automated Cell Culture System, ImageXpress® HCS.ai High-Content Screening System, and IN Carta® Image Analysis Software streamlines anticancer drug toxicity evaluation in patient-derived human intestinal organoids. By integrating suspension organoid culture, high-content imaging, and AI-driven phenotypic analysis, researchers can improve assay consistency, reduce workflow complexity, and generate more comprehensive toxicity insights.

In this application note, you'll learn how to:

Heading
Register to download the application note today!
Product family
Imaging
Product primary application
CellXpress.ai Automated Cell Culture System; IN Carta Image Analysis Software; ImageXpress HCS.ai High-Content Screening System; Lab automation for high-throughput clone screening; 3D Cell Models; Automated Cell Culture; Cell Imaging & Analysis; Intestinal Organoids; Live Cell Imaging; Organoids; Spheroids; Cancer Research Solutions; Disease Modeling; Drug Discovery and Development; Organoid Innovation Center; Toxicology
CMP
701Nr00000xsPfQIAU
Title
An automated workflow for anti cancer drug toxicity evaluation using patient derived healthy intestinal organoids with suspension culture and AI enabled image analysis
Resource URL
Resource Link
Resource Image URL
Application note on Human Intestinal Organoid Screening

Learn more about the systems behind the methods:

More great resources